References
- Chaffer CL, Brueckmann I, Scheel C, et al (2011). Normal and neoplastic nonstem cells can spontaneously convert to a stemlike state. Proc Natl Acad Sci USA, 108, 7950-5. https://doi.org/10.1073/pnas.1102454108
- Garraway LA, Janne PA (2012). Circumventing cancer drug resistance in the era of personalized medicine. Cancer Discov, 2, 214-26. https://doi.org/10.1158/2159-8290.CD-12-0012
- Han R, Xiong J, Xiao R, et al (2013). Activation of beta-catenin signaling is critical for doxorubicin-induced epithelialmesenchymal transition in BGC-823 gastric cancer cell line. Tumour Biol, 34, 277-84. https://doi.org/10.1007/s13277-012-0548-3
- Haslehurst AM, Koti M, et al (2012). EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer. BMC Cancer, 12, 91. https://doi.org/10.1186/1471-2407-12-91
- Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG (2013). Cancer drug resistance: an evolving paradigm. Nat Rev Cancer, 13, 714-26. https://doi.org/10.1038/nrc3599
- Iyer NG, Ozdag H, Caldas C (2004). p300/CBP and cancer. Oncogene, 23, 4225-31. https://doi.org/10.1038/sj.onc.1207118
- Kim MC, Cui FJ, Kim Y (2013). Hydrogen peroxide promotes epithelial to mesenchymal transition and stemness in human malignant mesothelioma cells. Asian Pac J Cancer Prev, 14, 3625-30. https://doi.org/10.7314/APJCP.2013.14.6.3625
- Li Y, Zhang X, Polakiewicz RD, Yao TP, Comb MJ (2008). HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization. J Biol Chem, 283, 12686-90. https://doi.org/10.1074/jbc.C700185200
- Mak AB, Nixon AM, Kittanakom S, et al (2012). Regulation of CD133 by HDAC6 promotes beta-catenin signaling to suppress cancer cell differentiation. Cell Rep, 2, 951-63. https://doi.org/10.1016/j.celrep.2012.09.016
- Sarkar FH, Li Y, Wang Z, Kong D (2009). Pancreatic cancer stem cells and EMT in drug resistance and metastasis. Minerva Chir, 64, 489-500.
- Scheel C, Eaton EN, Li SH, et al (2011). Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell, 145, 926-40. https://doi.org/10.1016/j.cell.2011.04.029
- Sharma SV, Lee DY, Li B, et al (2010). A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell, 141, 69-80. https://doi.org/10.1016/j.cell.2010.02.027
- Shi D, Pop MS, Kulikov R, et al (2009). CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53. Proc Natl Acad Sci USA, 106, 16275-80. https://doi.org/10.1073/pnas.0904305106
- Singh A, Settleman J (2010). EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene, 29, 4741-51. https://doi.org/10.1038/onc.2010.215
- Suva ML, Riggi N, Bernstein BE (2013). Epigenetic reprogramming in cancer. Science, 339, 1567-70. https://doi.org/10.1126/science.1230184
- Wolf D, Rodova M, Miska EA, Calvet JP, Kouzarides T (2002). Acetylation of beta-catenin by CREB-binding protein (CBP). J Biol Chem, 277, 25562-7. https://doi.org/10.1074/jbc.M201196200
- Yang J, Weinberg RA (2008). Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell, 14, 818-29. https://doi.org/10.1016/j.devcel.2008.05.009
- Yang M, Waterman ML, Brachmann RK (2008). hADA2a and hADA3 are required for acetylation, transcriptional activity and proliferative effects of beta-catenin. Cancer Biol Ther, 7, 120-8. https://doi.org/10.4161/cbt.7.1.5197
- Zahreddine H, Borden KL (2013). Mechanisms and insights into drug resistance in cancer. Front Pharmacol, 4, 28.
- Zhu QC, Gao RY, Wu W, Qin HL (2013). Epithelial-mesenchymal transition and its role in the pathogenesis of colorectal cancer. Asian Pac J Cancer Prev, 14, 2689-98. https://doi.org/10.7314/APJCP.2013.14.5.2689
Cited by
- Mechanism of Fatty Acid Synthase in Drug Tolerance Related to Epithelial-mesenchymal Transition of Breast Cancer vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7617
- Short Low Concentration Cisplatin Treatment Leads to an Epithelial Mesenchymal Transition-like Response in DU145 Prostate Cancer Cells vol.16, pp.3, 2015, https://doi.org/10.7314/APJCP.2015.16.3.1025
- Long Non-coding RNAs and Drug Resistance vol.16, pp.18, 2015, https://doi.org/10.7314/APJCP.2015.16.18.8067
- Tamoxifen reverses epithelial–mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells vol.17, pp.1, 2017, https://doi.org/10.1186/s12885-017-3457-4
- The inhibitory effects of deep-sea water on doxorubicin-induced epithelial-mesenchymal transition vol.38, pp.2, 2017, https://doi.org/10.3892/or.2017.5726
- Notch signaling is important for epithelial-mesenchymal transition induced by low concentrations of doxorubicin in osteosarcoma cell lines vol.13, pp.4, 2017, https://doi.org/10.3892/ol.2017.5708
- Histone acetyltransferase p300/CBP inhibitor C646 blocks the survival and invasion pathways of gastric cancer cell lines vol.51, pp.6, 2017, https://doi.org/10.3892/ijo.2017.4176